SARGRAMOSTIM for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 17 adverse event reports in the FDA FAERS database where SARGRAMOSTIM was used for Prostate cancer.
Most Reported Side Effects for SARGRAMOSTIM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 98 | 16.5% | 12 | 10 |
| Pyrexia | 76 | 12.8% | 3 | 23 |
| Pain | 56 | 9.4% | 2 | 1 |
| Hospitalisation | 31 | 5.2% | 0 | 24 |
| Death | 30 | 5.1% | 29 | 0 |
| Hypotension | 25 | 4.2% | 3 | 18 |
| Device related infection | 23 | 3.9% | 1 | 1 |
| Cough | 20 | 3.4% | 1 | 4 |
| Febrile neutropenia | 20 | 3.4% | 1 | 5 |
| Disease progression | 18 | 3.0% | 9 | 1 |
| Device related bacteraemia | 17 | 2.9% | 0 | 0 |
| Fatigue | 16 | 2.7% | 1 | 8 |
| Hypersensitivity | 16 | 2.7% | 0 | 4 |
| Nausea | 16 | 2.7% | 3 | 2 |
| Injection site erythema | 14 | 2.4% | 0 | 0 |
Other Indications for SARGRAMOSTIM
Neuroblastoma (88)
Product used for unknown indication (48)
Alveolar proteinosis (44)
Pancreatic carcinoma (40)
Pancreatic carcinoma metastatic (39)
Neutropenia (35)
Adrenal gland cancer (26)
Malignant melanoma (24)
Neoplasm malignant (12)
Bladder cancer (7)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)